1. Background
1.1. Necessity of Developing a Specific Liver Transplantation Instrument
1.2. Liver Transplantation in Iran
2.Objectives
3. Materials and Methods
3.1. Item Generation
3.2. Item Reduction
3.2.1. Face Validity
3.2.2. Content Validity
3.2.3. Recheck Face Validity
3.2.4. Construct Validity
3.2.5. Convergent Validity
3.2.6. Reliability
3.2.7. Ethical Considerations
4. Results
| Items | Response Category |
|---|---|
| How satisfied are you with | very satisfied to very unsatisfied |
| 1. Health status | |
| 2. The amount of energy needed for ordinary routine activities | |
| 3. Ability to care for themselves without help from others | |
| 4. Ability to take on the responsibilities of family | |
| 5. Ability to meet financial needs | |
| 6. Ability to do fun activities and sports | |
| 7. Receive emotional support from family | |
| 8. Receive support from special foundations and charities a | |
| 9. Employment status (i.e., the ability to work at the moment) | |
| 10. Marital relationships and sex | |
| 11. Happiness and tranquility in the family | |
| 12. Tranquility of spirit | |
| 13. Relationship and Closeness with God | |
| 14. Appearance | |
| 15. Sense of vitality and exuberance | |
| 16. Achievement level of personal goals | |
| 17. Sense of control over life issues | |
| 18. Being useful to others | |
| 19. How to provide care after discharge and receiving training by the transplant team a | |
| 20. How to Provide psychology and counseling services after transplantation a | |
| 21. How people treat you as an individual who had liver transplant a | |
| 22. Back to normal life after liver transplantation | |
| 23. Life satisfaction in general | |
| How worried are you with | very worried to very unworried |
| 24. The cost of immunosuppressant drugs | |
| 25. Obtain immunosuppressant drugs | |
| 26. Taking several drugs simultaneously and forever | |
| 27. Possibility of Medical complications | |
| 28. Problems related to marriage and childbearing a | |
| 29. Financial costs generated following liver transplantation | |
| 30. The feeling of being a burden to family and society | |
| 31. Uncertainty about a happy, healthy and desired future | |
| 32. Lack of access to medical members of transplant team when necessary | |
| 33. Lack of available physicians familiar with transplantation issues in home town | |
| 34. Not care about your opinions in the treatment process | |
| 35. Lack of awareness and sufficient information about self-care | |
| 36. Recurrence of the underlying disease | |
| 37. Transplant rejection | |
| 38. Life In exchange for death of another persona | |
| How problematic for you? | very problematic to no problem |
| 39. Weakness and fatigue | |
| 40. Unusual increased appetite a | |
| 41. Pain in site of operation a | |
| 42. Scar formation in operation site | |
| 43. Biliary ducts complications | |
| 44.Unusual weight gain | |
| 45. Developed hyperglycemia after Transplantation | |
| 46. Developed hypertension after Transplantation | |
| 47. Difficulty in renal function (creatinine increase in experiments) | |
| 48. Hand tremor a | |
| 49. Osteoporosis (diagnosed by a physician) |
a deleted items in final version (after factor analysis)
| Data | |
|---|---|
| Age, y, Mean ± SD | 37.5 ± 12 |
| Sex, % | |
| Male | 63.3 |
| Female | 36.7 |
| Education, % | |
| Academic education | 19.6 |
| Diploma and under diploma | 80.4 |
| Marital status, % | |
| Married | 69.7 |
| Single | 30.3 |
| Employment, % | |
| Employed | 44.6 |
| Unemployed | 21.1 |
| Housekeeper | 24.4 |
| Student | 9.9 |
| Underlying disease, % | |
| Hepatitis | 25.2 |
| PSC | 12.6 |
| Cirrhosis | 42.1 |
| Autoimmune | 5 |
| Others | 15.1 |
| Factor Analysis, Questionnaire Items | Component | ||
|---|---|---|---|
| 1 | 2 | 3 | |
| q1 | 0.666 | 0.160 | 0.167 |
| q2 | 0.599 | -0.053 | 0.010 |
| q3 | 0.741 | -0.010 | -0.048 |
| q4 | 0.721 | 0.130 | -0.034 |
| q5 | 0.555 | 0.385 | -0.220 |
| q6 | 0.751 | 0.072 | -0.046 |
| q7 | 0.481 | 0.143 | 0.155 |
| q8 | 0.170 | 0.371 | -0.006 |
| q9 | 0.590 | 0.182 | -0.140 |
| q10 | 0.578 | 0.245 | 0.043 |
| q11 | 0.723 | 0.054 | 0.204 |
| q12 | 0.711 | 0.192 | 0.096 |
| q13 | 0.514 | 0.021 | 0.215 |
| q14 | 0.722 | 0.191 | -0.106 |
| q15 | 0.811 | 0.175 | 0.055 |
| q16 | 0.736 | 0.348 | -0.148 |
| q17 | 0.810 | 0.072 | 0.112 |
| q18 | 0.716 | 0.002 | 0.019 |
| q19 | 0.097 | 0.259 | 0.312 |
| q20 | 0.241 | 0.237 | 0.245 |
| q21 | 0.262 | 0.172 | 0.044 |
| q22 | 0.660 | 0.184 | 0.107 |
| q23 | 0.606 | 0.262 | 0.129 |
| q24 | 0.290 | 0.673 | -0.191 |
| q25 | 0.178 | 0.701 | -0.137 |
| q26 | 0.376 | 0.584 | 0.017 |
| q27 | 0.150 | 0.498 | 0.127 |
| q28 | 0.339 | 0.323 | 0.221 |
| q29 | 0.356 | 0.675 | -0.119 |
| q30 | 0.538 | 0.370 | 0.060 |
| q31 | 0.516 | 0.411 | 0.189 |
| q32 | 0.098 | 0.559 | 0.237 |
| q33 | 0.072 | 0.464 | 0.337 |
| q34 | 0.130 | 0.680 | 0.281 |
| q35 | -0.073 | 0.416 | 0.325 |
| q36 | 0.127 | 0.683 | 0.126 |
| q37 | 0.054 | 0.535 | -0.066 |
| q38 | -0.081 | 0.209 | 0.095 |
| q39 | 0.439 | 0.267 | 0.311 |
| q40 | 0.141 | 0.283 | -0.016 |
| q41 | 0.155 | -0.003 | 0.263 |
| q42 | -0.014 | 0.265 | 0.541 |
| q43 | 0.290 | 0.130 | 0.456 |
| q44 | -0.166 | -0.016 | 0.528 |
| q45 | -0.092 | 0.085 | 0.748 |
| q46 | -0.085 | 0.138 | 0.753 |
| q47 | 0.146 | -0.038 | 0.639 |
| q48 | 0.081 | -0.198 | 0.381 |
| q49 | 0.089 | 0.039 | 0.600 |
| Eigenvalue | 12.63 | 4.216 | 3.11 |
| Explained variance, % | 21.118 | 11.440 | 8.172 |
| No. of items | Mean (SD) a | Skewness | Cronbach’ alpha | |
|---|---|---|---|---|
| Health Satisfaction | 21 | 67.113 (11.968) | -0.824 | 0.92 |
| Concerns | 12 | 31.194 (8.223) | 0.001 | 0.84 |
| Complications | 7 | 23.613 (4.496) | -1.560 | 0.76 |
a Scores range from 21 to 84 for Health Satisfaction, 12 to 48 for Concerns, and 7 to 28 for Complication. Higher scores indicate better quality of life